These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18386187)

  • 1. Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.
    Chwajol M; Starke RM; Kim GH; Mayer SA; Connolly ES
    Neurocrit Care; 2008; 8(3):418-26. PubMed ID: 18386187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage.
    Starke RM; Kim GH; Fernandez A; Komotar RJ; Hickman ZL; Otten ML; Ducruet AF; Kellner CP; Hahn DK; Chwajol M; Mayer SA; Connolly ES
    Stroke; 2008 Sep; 39(9):2617-21. PubMed ID: 18658042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
    Roos YB; Rinkel GJ; Vermeulen M; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (2):CD001245. PubMed ID: 12804399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
    Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
    J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebleeding after aneurysmal subarachnoid hemorrhage.
    Starke RM; Connolly ES;
    Neurocrit Care; 2011 Sep; 15(2):241-6. PubMed ID: 21761274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study.
    Kassell NF; Torner JC; Adams HP
    J Neurosurg; 1984 Aug; 61(2):225-30. PubMed ID: 6737046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of early rebleeding.
    Iplikçioglu AC; Bek S
    J Neurosurg; 2003 May; 98(5):1147; author reply 1148. PubMed ID: 12744386
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of early rebleeding.
    Roos Y; Vermeulen M
    J Neurosurg; 2003 May; 98(5):1148-9; author reply 1149-50. PubMed ID: 12744388
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group.
    Roos Y
    Neurology; 2000 Jan; 54(1):77-82. PubMed ID: 10636129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of short-term ε-aminocaproic acid treatment on patients undergoing endovascular coil embolization following aneurysmal subarachnoid hemorrhage.
    Malekpour M; Kulwin C; Bohnstedt BN; Radmand G; Sethia R; Mendenhall SK; Weyhenmeyer J; Hendricks BK; Leipzig T; Payner TD; Shah MV; Scott J; DeNardo A; Sahlein D; Cohen-Gadol AA
    J Neurosurg; 2017 May; 126(5):1606-1613. PubMed ID: 27315025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis.
    Gaberel T; Magheru C; Emery E; Derlon JM
    Acta Neurochir (Wien); 2012 Jan; 154(1):1-9; discussion 9. PubMed ID: 22002504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrinolytic therapy in the treatment of aneurysmal subarachnoid hemorrhage.
    Kassell NF; Haley EC; Torner JC
    Clin Neurosurg; 1986; 33():137-45. PubMed ID: 3491721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.
    Leipzig TJ; Redelman K; Horner TG
    J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review.
    Roos Y; Rinkel G; Vermeulen M; Algra A; van Gijn J
    Stroke; 2003 Sep; 34(9):2308-9. PubMed ID: 12933970
    [No Abstract]   [Full Text] [Related]  

  • 15. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus.
    Harrigan MR; Rajneesh KF; Ardelt AA; Fisher WS
    Neurosurgery; 2010 Oct; 67(4):935-9; discussion 939-40. PubMed ID: 20881558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review.
    Larsen CC; Astrup J
    World Neurosurg; 2013 Feb; 79(2):307-12. PubMed ID: 22722033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study.
    Pinna G; Pasqualin A; Vivenza C; Da Pian R
    Acta Neurochir (Wien); 1988; 93(3-4):77-87. PubMed ID: 3177035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of early rebleeding.
    Lanzino G; Wang H
    J Neurosurg; 2003 May; 98(5):1146-7; author reply 1148. PubMed ID: 12744385
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of early rebleeding.
    Schisano G; Nina P
    J Neurosurg; 2003 May; 98(5):1147-8; author reply 1148. PubMed ID: 12744387
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: A case-control study.
    Foreman PM; Chua M; Harrigan MR; Fisher WS; Tubbs RS; Shoja MM; Griessenauer CJ
    Clin Neurol Neurosurg; 2015 Dec; 139():66-9. PubMed ID: 26378393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.